Bleomycin pharmacokinetics in man

[1]  S. Crooke,et al.  Effects of variations in renal function on the clinical pharmacology of bleomycin administered as an iv bolus. , 1977, Cancer treatment reports.

[2]  S. Crooke,et al.  Specificity of antisera produced against bleomycin. , 1977, Cancer treatment reports.

[3]  S. Crooke,et al.  Bleomycin serum pharmacokinetics as determined by a radioimmunoassay and a microbiologic assay in a patient with compromised renal function , 1977, Cancer.

[4]  J. Horton,et al.  Intracavitary bleomycin in the management of malignant effusions , 1976, Cancer.

[5]  J. Wagner,et al.  CSTRIP, a fortran IV computer program for obtaining initial polyexponential parameter estimates. , 1976, Journal of pharmaceutical sciences.

[6]  J. Strong,et al.  Radioimmunoassay of bleomycin. , 1976, Cancer research.

[7]  J. Holland,et al.  Microbiological assay of bleomycin: Inactivation, tissue distribution, and clearance , 1974, Cancer.

[8]  Harold G. Boxenbaum,et al.  Statistical estimations in pharmacokinetics , 1974, Journal of Pharmacokinetics and Biopharmaceutics.

[9]  T. Takita,et al.  CHEMISTRY OF BLEOMYCIN. XI , 1973 .

[10]  S. Carter,et al.  A clinical review of bleomycin—a new antineoplastic agent , 1973, Cancer.

[11]  J. Smith,et al.  Bleomycin, an antitumor antibiotic. Clinical experience in 274 patients. , 1972, Annals of internal medicine.

[12]  S B Lucas,et al.  Computer-assisted prescribing of kanamycin for patients with renal insufficiency. , 1972, Lancet.

[13]  T. Takeuchi,et al.  New antibiotics, bleomycin A and B. , 1966, The Journal of antibiotics.

[14]  V. Devita,et al.  Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer. , 1978, Cancer treatment reports.

[15]  R. Benjamin,et al.  Clinical pharmacology of bleomycin by radioimmunoassay , 1977 .